speb/financial-data huggingface dataset:
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 612900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 659800000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 3300000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 3300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8487300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 125600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 6061400000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 49600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 49600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 445800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Net Income: 262900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 262900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 262900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 262900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 262900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 262900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -3300000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -3300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 612900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 8458600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 182700000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 395700000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 262900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Operating Income: 195800000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 2135100000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 26325306.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 356000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2458600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 8224000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 28700000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 119200000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1300000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 161600000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 425700000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 611300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1600000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 3300000000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Payables: 157900000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 354100000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1475300000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 38300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 26325306.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 8487300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 8458600000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 91200000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 12295800000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 8487300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 78900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 8487300000.00
NUCLEUS.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 1939300000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3808500000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 7054000000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 682900000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 10700000.00
NUCLEUS.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 2116200000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 462800000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2200300000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 26335878.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 7.86
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1448600000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 43300000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 43300000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 26335878.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 7.86
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 207000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — EBIT: 251600000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 294900000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 751700000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 5000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 5000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Net Income: 207000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 207000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 207000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 207000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 207000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 207000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -5000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -5000000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 483400000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 365229927.01
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 288900000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2200300000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 151200000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 419500000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 188500000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 246600000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1448600000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 43300000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -188500000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -30270072.99
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 39600000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.16
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1911400000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -188500000.00
NUCLEUS.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -188500000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1541500000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 432700000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 8760300000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2247700000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 182100000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 182100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1048100000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1048100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -643900000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -643900000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 60600000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 60600000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1700000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1700000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 3437900000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 3437900000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 26325306.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 26333841.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Basic EPS: 44.35
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 13.12
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 504600000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 411100000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 411100000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -283700000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 85500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 85500000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 263300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 263300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 797100000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 797100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4132500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4132500000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -329100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 334900000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 334900000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 462200000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 462200000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -100700000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Change In Payable: 55000000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 185100000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 402700000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 283300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 263300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 263300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 9074500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 9074500000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Common Stock Payments: 0.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 900000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 900000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 6128000000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1514700000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 5892300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 5892300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 36400000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 36400000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 36400000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 36400000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Current Deferred Assets: 800000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 800000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 11300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 11300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 2822400000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2822400000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 71800000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 71800000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 49700000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Depreciation: 164900000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 164900000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 164900000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 49300000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 164900000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 49300000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 26325306.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 26333841.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Diluted EPS: 44.35
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 13.12
NUCLEUS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1167400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 345500000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 2800000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 2800000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 0.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — EBIT: 1506700000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — EBIT: 418500000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — EBITDA: 1671600000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 467800000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 12200000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 800100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2293000000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2293000000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -365000000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 890900000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -271300000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -3100000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 191100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 29500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 29500000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 1049800000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 1049800000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 1382000000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1382000000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Gross Profit: 2632300000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 733000000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 0.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 0.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Held To Maturity Securities: 214300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 214300000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Interest Expense: 7900000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 3400000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 7900000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3400000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Interest Income: 304900000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 304900000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -6400000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 24800000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 9074500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 9074500000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -526300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 124100000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 124100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 5730900000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 5730900000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 51700000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 51700000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 49100000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 49100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 49100000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 49100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 583600000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 583600000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 918300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 918300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 0.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 0.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -41000000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Net Income: 1167400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Net Income: 345500000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1167400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 345500000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1167400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 345500000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1167400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 345500000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1167400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 345500000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1498800000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1167400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 345500000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Net Interest Income: 290800000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -3400000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -269100000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 290800000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3400000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 738100000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 738100000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -282000000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 9045000000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 9045000000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 127500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 127500000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 29800000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 29800000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1616700000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 498800000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Normalized Income: 1124638951.16
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 371302216.33
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1174600000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Operating Income: 1090800000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Operating Income: 300300000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Operating Revenue: 8760300000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2247700000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 26325306.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 26325306.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 514300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 514300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 1774200000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1774200000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 8811200000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 8811200000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 29500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 29500000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -287300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 100000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 1200000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1200000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 2900000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 149200000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 582500000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 383400000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Payable: 893800000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 893800000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Properties: 737300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 737300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 481300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 481300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 3335400000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3335400000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Other Special Charges: 216400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: 31000000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Payables: 1078700000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1078700000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 215900000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 215900000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Pretax Income: 1498800000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 415100000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -283700000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 6128000000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1514700000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 164900000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 49300000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 30700000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 30700000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: 0.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 8900000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 8900000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 8536200000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 8536200000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 1700000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 105900000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 297000000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Share Issued: 26325306.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 26325306.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Special Income Charges: -216400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -31000000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 9074500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 9074500000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 9045000000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 9045000000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 12138951.16
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -5197783.67
NUCLEUS.NS income_statement (annual, 2026-03-31) — Tax Provision: 331400000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 69600000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.22
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.17
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 4800000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 4800000.00
NUCLEUS.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -339300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Total Assets: 12661300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 12661300000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 9074500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 9074500000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Total Debt: 85500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 85500000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 9074500000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 9074500000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Total Expenses: 7669500000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1947400000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 3586800000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3586800000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 6769000000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 6769000000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 764400000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 764400000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 6200000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 11300000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 11300000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 54900000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -31000000.00
NUCLEUS.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 54900000.00
NUCLEUS.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -31000000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Trading Securities: 873700000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Trading Securities: 873700000.00
NUCLEUS.NS balance_sheet (annual, 2026-03-31) — Working Capital: 3069900000.00
NUCLEUS.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 3069900000.00
NUE income_statement (annual, 2021-12-31) — Average Dilution Earnings: 121000.00
NUE balance_sheet (annual, 2021-12-31) — Dividends Payable: 137600000.00
NUE income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 62161000.00
NUE balance_sheet (annual, 2021-12-31) — Leases: 96000000.00
NUE balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 1100455000.00
NUE balance_sheet (annual, 2021-12-31) — Other Payable: 143800000.00
NUE balance_sheet (annual, 2021-12-31) — Other Properties: 558336000.00
NUE income_statement (annual, 2022-12-31) — +Operating Expense: 1997000000.00
NUE income_statement (annual, 2022-12-31) — +Total Revenue: 41512000000.00
NUE balance_sheet (annual, 2022-12-31) — Accounts Payable: 1649523000.00
NUE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3591030000.00
NUE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -11115127000.00
NUE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2143520000.00
NUE balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -200200000.00
NUE cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 235000000.00
NUE cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 235000000.00
NUE income_statement (annual, 2022-12-31) — Average Dilution Earnings: 115000.00
NUE income_statement (annual, 2022-12-31) — Basic Average Shares: 262348000.00
NUE income_statement (annual, 2022-12-31) — Basic EPS: 28.88
NUE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2509000000.00
NUE balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 2230672000.00
NUE cash_flow (annual, 2022-12-31) — Capital Expenditure: -1948000000.00
NUE cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -1948000000.00
NUE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 206968000.00
NUE balance_sheet (annual, 2022-12-31) — Capital Stock: 152061000.00
NUE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4280852000.00
NUE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 4857798000.00
NUE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -534000000.00
NUE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -2511000000.00
NUE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -5703000000.00
NUE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 10072000000.00
NUE cash_flow (annual, 2022-12-31) — Change In Account Payable: -496000000.00
NUE cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 155000000.00
NUE cash_flow (annual, 2022-12-31) — Change In Inventory: 962000000.00
NUE cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -429000000.00
NUE cash_flow (annual, 2022-12-31) — Change In Payable: -496000000.00
NUE cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -341000000.00
NUE cash_flow (annual, 2022-12-31) — Change In Receivables: 501000000.00
NUE cash_flow (annual, 2022-12-31) — Change In Working Capital: 693000000.00
NUE cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 501000000.00
NUE cash_flow (annual, 2022-12-31) — Changes In Cash: 1858000000.00
NUE balance_sheet (annual, 2022-12-31) — Common Stock: 152061000.00
NUE cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -534000000.00
NUE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 18414694000.00
NUE cash_flow (annual, 2022-12-31) — Common Stock Payments: -2763000000.00
NUE balance_sheet (annual, 2022-12-31) — Construction In Progress: 1815638000.00
NUE income_statement (annual, 2022-12-31) — Cost Of Revenue: 29009000000.00
NUE balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 2602558000.00
NUE balance_sheet (annual, 2022-12-31) — Current Assets: 14691684000.00
NUE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 18582000.00
NUE balance_sheet (annual, 2022-12-31) — Current Debt: 59081000.00
NUE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 77663000.00
NUE balance_sheet (annual, 2022-12-31) — Current Liabilities: 4329744000.00
NUE cash_flow (annual, 2022-12-31) — Deferred Income Tax: -47000000.00
NUE cash_flow (annual, 2022-12-31) — Deferred Tax: -47000000.00
NUE cash_flow (annual, 2022-12-31) — Depreciation: 827000000.00
NUE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1062000000.00
NUE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1062000000.00
NUE income_statement (annual, 2022-12-31) — Diluted Average Shares: 263176000.00
NUE income_statement (annual, 2022-12-31) — Diluted EPS: 28.79
NUE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 7607000000.00
NUE cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 57000000.00
NUE balance_sheet (annual, 2022-12-31) — Dividends Payable: 130500000.00
NUE income_statement (annual, 2022-12-31) — EBIT: 10506000000.00
NUE income_statement (annual, 2022-12-31) — EBITDA: 11568000000.00
NUE income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 11000000.00
NUE cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -11000000.00
NUE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -6000000.00
NUE cash_flow (annual, 2022-12-31) — End Cash Position: 4361000000.00
NUE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -2511000000.00
NUE cash_flow (annual, 2022-12-31) — Free Cash Flow: 8124000000.00
NUE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -137517000.00
NUE balance_sheet (annual, 2022-12-31) — Goodwill: 3920060000.00
NUE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 7242325000.00
NUE balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 3791230000.00
NUE balance_sheet (annual, 2022-12-31) — Gross PPE: 20732047000.00
NUE income_statement (annual, 2022-12-31) — Gross Profit: 12503000000.00
NUE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 101756000.00
NUE income_statement (annual, 2022-12-31) — Interest Expense: 218911000.00
NUE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 218911000.00
NUE income_statement (annual, 2022-12-31) — Interest Income: 48695000.00
NUE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 48695000.00
NUE balance_sheet (annual, 2022-12-31) — Inventory: 5453531000.00
NUE balance_sheet (annual, 2022-12-31) — Invested Capital: 24899076000.00
NUE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -5703000000.00
NUE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2092000000.00
NUE balance_sheet (annual, 2022-12-31) — Land And Improvements: 905598000.00
NUE balance_sheet (annual, 2022-12-31) — Leases: 96000000.00
NUE balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 188386000.00
NUE balance_sheet (annual, 2022-12-31) — Long Term Debt: 6425301000.00
NUE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 6613687000.00
NUE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 2092000000.00
NUE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1111000000.00
NUE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 15125653000.00
NUE balance_sheet (annual, 2022-12-31) — Minority Interest: 1155212000.00
NUE income_statement (annual, 2022-12-31) — Minority Interests: -472000000.00
NUE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -3453000000.00
NUE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -2763000000.00
NUE balance_sheet (annual, 2022-12-31) — Net Debt: 2203530000.00
NUE income_statement (annual, 2022-12-31) — Net Income: 7607000000.00
NUE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 7607000000.00
NUE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 8079000000.00
NUE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 7607000000.00
NUE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 7607000000.00
NUE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 8079000000.00
NUE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 8079000000.00
NUE income_statement (annual, 2022-12-31) — Net Interest Income: -170000000.00
NUE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -324000000.00
NUE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 922000000.00
NUE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 981000000.00
NUE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -170000000.00
NUE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -159000000.00
NUE cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -10000000.00
NUE balance_sheet (annual, 2022-12-31) — Net PPE: 9616920000.00
NUE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 32000000.00
NUE cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -59000000.00
NUE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 11172369000.00
NUE balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 1965873000.00
NUE income_statement (annual, 2022-12-31) — Normalized EBITDA: 11670000000.00
NUE income_statement (annual, 2022-12-31) — Normalized Income: 7687447400.00
NUE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 10072000000.00
NUE cash_flow (annual, 2022-12-31) — Operating Gains Losses: 91000000.00
NUE income_statement (annual, 2022-12-31) — Operating Income: 10506000000.00
NUE income_statement (annual, 2022-12-31) — Operating Revenue: 41512000000.00
NUE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 253493000.00
NUE balance_sheet (annual, 2022-12-31) — Other Current Assets: 789325000.00
NUE balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 59081000.00
NUE balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -137517000.00
NUE income_statement (annual, 2022-12-31) — Other Income Expense: -91000000.00
NUE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 3322265000.00
NUE balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 928281000.00
NUE balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1965873000.00
NUE balance_sheet (annual, 2022-12-31) — Other Payable: 163600000.00
NUE balance_sheet (annual, 2022-12-31) — Other Properties: 558486000.00
NUE balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 576946000.00
NUE income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 31172000.00
NUE balance_sheet (annual, 2022-12-31) — Payables: 1649523000.00
NUE balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4252081000.00
NUE income_statement (annual, 2022-12-31) — Pretax Income: 10245000000.00
NUE cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 23000000.00
NUE cash_flow (annual, 2022-12-31) — Purchase Of Business: -3553000000.00
NUE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -914000000.00
NUE balance_sheet (annual, 2022-12-31) — Receivables: 3591030000.00
NUE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 29009000000.00
NUE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1062000000.00
NUE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1111000000.00
NUE cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -2763000000.00
NUE balance_sheet (annual, 2022-12-31) — Retained Earnings: 24754873000.00
NUE cash_flow (annual, 2022-12-31) — Sale Of Business: 100000000.00
NUE cash_flow (annual, 2022-12-31) — Sale Of Investment: 590000000.00
NUE cash_flow (annual, 2022-12-31) — Sale Of PPE: 32000000.00
NUE income_statement (annual, 2022-12-31) — Selling General And Administration: 1997000000.00
NUE balance_sheet (annual, 2022-12-31) — Share Issued: 380154000.00
NUE income_statement (annual, 2022-12-31) — Special Income Charges: -102000000.00
NUE cash_flow (annual, 2022-12-31) — Stock Based Compensation: 137000000.00
NUE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 18414694000.00
NUE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 11172369000.00
NUE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -21552600.00
NUE income_statement (annual, 2022-12-31) — Tax Provision: 2166000000.00
NUE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
NUE balance_sheet (annual, 2022-12-31) — Total Assets: 32479210000.00
NUE balance_sheet (annual, 2022-12-31) — Total Capitalization: 24839995000.00
NUE balance_sheet (annual, 2022-12-31) — Total Debt: 6691350000.00
NUE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 19569906000.00
NUE income_statement (annual, 2022-12-31) — Total Expenses: 31006000000.00
NUE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 12909304000.00
NUE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 17787526000.00
NUE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 8579560000.00
NUE income_statement (annual, 2022-12-31) — Total Other Finance Cost: 170000000.00
NUE income_statement (annual, 2022-12-31) — Total Unusual Items: -102000000.00
NUE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -102000000.00
NUE balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 126661000.00
NUE balance_sheet (annual, 2022-12-31) — Treasury Stock: 8498243000.00
NUE balance_sheet (annual, 2022-12-31) — Working Capital: 10361940000.00
NUE income_statement (annual, 2022-12-31) — Write Off: 102000000.00
NUE income_statement (annual, 2023-12-31) — +Operating Expense: 1585000000.00
NUE income_statement (annual, 2023-12-31) — +Total Revenue: 34714000000.00
NUE balance_sheet (annual, 2023-12-31) — Accounts Payable: 2020000000.00
NUE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2953000000.00
NUE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -11789000000.00
NUE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2176000000.00
NUE balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -127000000.00
NUE cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 238000000.00
NUE cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 238000000.00
NUE income_statement (annual, 2023-12-31) — Average Dilution Earnings: 49000.00
NUE income_statement (annual, 2023-12-31) — Basic Average Shares: 249773000.00
NUE income_statement (annual, 2023-12-31) — Basic EPS: 18.05
NUE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 4361000000.00
NUE balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 2551000000.00
NUE cash_flow (annual, 2023-12-31) — Capital Expenditure: -2214000000.00
NUE cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -2214000000.00
NUE balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 203000000.00
NUE balance_sheet (annual, 2023-12-31) — Capital Stock: 152000000.00
NUE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 6383000000.00
NUE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 7130000000.00
NUE cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -515000000.00
NUE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -2593000000.00
NUE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -2496000000.00
NUE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 7112000000.00
NUE cash_flow (annual, 2023-12-31) — Change In Account Payable: 361000000.00
NUE cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -291000000.00
NUE cash_flow (annual, 2023-12-31) — Change In Inventory: -75000000.00